Upload
tin180-vietnam
View
941
Download
0
Embed Size (px)
DESCRIPTION
Citation preview
04/11/23 © ePharmaMonitor 2008 1
i am looking for information on lymph nodes under arm pits i had a tumor in my lymph node last year had radiation and was told it went away 2 months later it started growing back 3 months later had a pet scan and my doctor said my blood work was good it is about 3 or 4 inches hard and it is turning purple i have to wait a month to see my doctor cause he's on vacation i think they are making me wait is cause i dont have health insurance and have to wait till a certain doctor gives his time for people who dont have insurance it keeps me up at night worrying and it hurts and sometimes it feels like it is getting pinched please if anyone has any information please let me know i called the hosipital i am going to and i get no where i even got hung up in one department
I developed neuropathy in my hands and feet. I take neurotin 4x a day, 300 mg. The neuropathy has leveled off, but has not improved. Has anyone's neuropathy improved to the point that medication is not needed?
Anne -- I stopped Taxol in Nov. 2005. I still have neuropathy and other symptoms which include severe fatigue. I initially took Neurotin but it was not effective. I take Lyrica 150 mg. bid. It has lessened the pain and numbness in my toes but not completely. I also have balance issues. Recently my falls have caused injuries (down stairs and backwards off of a ladder). I am doing PT. I am frustrated because I am unable to work due to the fatigue and I want to get on with my life. I know that this is not good news for you. I recently read that 18% of the women who had neuropathy more than two years out could expect it to continue. On the other hand 78% is a large group and you could be in that one. Good luck.
Anne, I have had neuropathy for several years. I take Neurontin, 1,800 mgs a day for something else; but it didn't help the neuropathy. What did help the neuropathy was taking low doses of Cymbalta, which is technically an anti-depressant. However, I only take 20 or 30 mgs at night; and it completely stops the neuropathy. I tried to stop taking it once; but the neuropathy was back in about 2 days. So, I stay on it.
I now take cymbalta for the peripheral neuropathy in the morning and then at 5 pm and 9 pm I take a 300 mgs of neurotin. In the interim, they cymbalta worked great, blocking the nerve pain. My doctor increased it to a second dose about 7 pm and eliminated the neurotin.
SOCIAL MEDIA: Listen, Everyone is Talking About YouWebinar: August 20th, 2008
04/11/23 © ePharmaMonitor 2008 2
Blogs
WikisForums
Podcasts
Video Sharing
Social Networks
Permission Based Marketing
Pharma
Consumer(Patient)
HCP(Physician, Nurses)
04/11/23 © ePharmaMonitor 2008 3
04/11/23 © ePharmaMonitor 2008 4
Source: iCrossing – How America Searches Health and Wellness January 2008
34%
04/11/23 © ePharmaMonitor 2008 5
Online applications,platforms and media which
drive interaction, collaborationand the sharing of content and
personal perspectives
04/11/23 © ePharmaMonitor 2008 6
ProfessionalOne third of online physicians use blogs, professional networks, forums, and message boards to connect with other physicians.
Patients &Consumers
20 million people use messageboards, communities, and blogs for health information today.
“Participate“
04/11/23 © ePharmaMonitor 2008 7
Learn. Acquire Skills. Research. Share. Educate.
04/11/23 © ePharmaMonitor 2008 8
Social media and multiple “value points”
04/11/23 © ePharmaMonitor 2008 9
This year we reached a possible tipping point,with trust in “a person like me” surpassing evenacademics and doctors in most countries
”
“
Edelman 2006 Trust Barometer
04/11/23 © ePharmaMonitor 2008 10
In light of their empowering social dynamics and volunteer economics, we suspect that patient-led online groups may prove to be a considerably more promising and sustainable health-care resource than professionally moderated therapy groups. ”
“
Dr. Dan Hoch, Board-certified epilepsy specialist,Department of Neurology at Massachusetts General Hospital
04/11/23 © ePharmaMonitor 2008 11
Regulatory, Legal, Payers, Associations… and so on.
04/11/23 © ePharmaMonitor 2008 12
Who? How? Why?
04/11/23 © ePharmaMonitor 2008 13
Less control
More complicated
More dangerous
OLD NEW
04/11/23 © ePharmaMonitor 2008 14
Percentage of all physicians go online for professional purposes
60%
97%
Online Physicians Reporting they Use or Are Interested in Using Online Physician Communities
60%US online consumers researching health-related topics online
33%US online consumers who have used at least one form of Social Computing for healthcare related purposes within the past 12 months
04/11/23 © ePharmaMonitor 2008 15
All marketing will become interactive.”“ Forrester Report, US Interactive Marketing Forecast, 2007 To 2012, October 10, 2007
04/11/23 © ePharmaMonitor 2008 16
To succeed in 2007, brand communications must not only be transparent, but offer some additional value before the audience will even tune in.”
“Hayes Roth, Chief Marketing OfficerLandor Associates
04/11/23 © ePharmaMonitor 2008 17
Clinical &Detached
EmotionallyDirect & Honest
One Way Communication
Two Way Dialogue
Forums &Community
Product & DiseaseInformation
Condition Tools& Resources
04/11/23 © ePharmaMonitor 2008 18
Clinical &Detached
EmotionallyDirect & Honest
One Way Communication
Two Way Dialogue
Forums &Community
Product & DiseaseInformation
Condition Tools& Resources
Health Specialists
Quality of Life
Disease Focus
04/11/23 © ePharmaMonitor 2008 19
Extended caregiver and support networks
04/11/23 © ePharmaMonitor 2008 20
kwazykelli
Feb 2008 April 2008 June 2008
25, 992
36, 163
46,755
19, 17822, 167
24, 397
August 2008
26, 365
56,126
Where are your COLs and POLs?
04/11/23 © ePharmaMonitor 2008 21
Relinking the conversion chains.
04/11/23 © ePharmaMonitor 2008 22
Listen. Observe. Engage.
04/11/23 © ePharmaMonitor 2008 23
Therapeutic AreaOpportunity.
04/11/23 © ePharmaMonitor 2008 24
Infertility treatment (clinic)Monitoring and ContentStrategy Optimization
Patient Content Rankingand Ratings
Extension of Core BrandValues Via Patient Exchange
Cautious = Limited Value
04/11/23 © ePharmaMonitor 2008 25
I’m a…
Creator
Critic
Collector
Joiner
Spectator
04/11/23 © ePharmaMonitor 2008 26
Cost Risk LevelDepth of
FeedbackPolicyEffort
Social Media Activity
Social Monitoring drivinge-content strategy
Targeted Social andCollaboration Pilot
Integrated Social and Community Experience
ConversionImpact
04/11/23 © ePharmaMonitor 2008 27
eStrategy
CustomerPersonas
OrganizationalBuy-in / Policy
MeasurementPlan
04/11/23 © ePharmaMonitor 2008 28
Thank you. Open forum for questions.